- Home
- KNOP vs SCPH Comparison
KNOP vs SCPH Comparison
Compare KNOP & SCPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KNOP
- SCPH
- Stock Information
- Founded
- KNOP 2013
- SCPH 2013
- Country
- KNOP United Kingdom
- SCPH United States
- Employees
- KNOP N/A
- SCPH N/A
- Industry
- KNOP Marine Transportation
- SCPH Biotechnology: Pharmaceutical Preparations
- Sector
- KNOP Consumer Discretionary
- SCPH Health Care
- Exchange
- KNOP Nasdaq
- SCPH Nasdaq
- Market Cap
- KNOP 243.9M
- SCPH 299.0M
- IPO Year
- KNOP 2013
- SCPH 2017
- Fundamental
- Price
- KNOP $8.60
- SCPH $5.63
- Analyst Decision
- KNOP
- SCPH Buy
- Analyst Count
- KNOP 0
- SCPH 3
- Target Price
- KNOP N/A
- SCPH $12.00
- AVG Volume (30 Days)
- KNOP 63.1K
- SCPH 2.3M
- Earning Date
- KNOP 09-25-2025
- SCPH 11-12-2025
- Dividend Yield
- KNOP 1.21%
- SCPH N/A
- EPS Growth
- KNOP N/A
- SCPH N/A
- EPS
- KNOP 0.19
- SCPH N/A
- Revenue
- KNOP $320,026,000.00
- SCPH $49,969,000.00
- Revenue This Year
- KNOP $9.01
- SCPH $108.95
- Revenue Next Year
- KNOP $0.42
- SCPH $78.30
- P/E Ratio
- KNOP $45.61
- SCPH N/A
- Revenue Growth
- KNOP 8.76
- SCPH 107.79
- 52 Week Low
- KNOP $5.28
- SCPH $1.94
- 52 Week High
- KNOP $9.00
- SCPH $6.28
- Technical
- Relative Strength Index (RSI)
- KNOP 66.77
- SCPH 64.37
- Support Level
- KNOP $7.74
- SCPH $4.33
- Resistance Level
- KNOP $9.00
- SCPH $5.62
- Average True Range (ATR)
- KNOP 0.36
- SCPH 0.05
- MACD
- KNOP 0.08
- SCPH 0.01
- Stochastic Oscillator
- KNOP 78.02
- SCPH 93.75
About KNOP KNOT Offshore Partners LP Common Units representing Limited Partner Interests
KNOT Offshore Partners LP owns, operates, and shuttles tankers under long-term charters in the North Sea and Brazil. The company provides crude oil loading, transportation, and storage services under time charters and bareboat charters. The Partnership is formed for acquiring ownership interests in over four shuttle tankers owned by Knutsen NYK Offshore Tankers AS (KNOT). It operates through the shuttle tanker market segment.
About SCPH scPharmaceuticals Inc.
scPharmaceuticals Inc is a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care, and reduce healthcare costs. The company's main product is Furoscix to treat congestion in patients with heart failure and edema in patients with chronic kidney disease. Furoscix is a novel formulation of furosemide contained in a pre-filled, Crystal Zenith cartridge and self-administered subcutaneously via a single-use, disposable, and wearable on-body delivery system.